Why do life sciences deals fail? Insights from industry dealmakers

Dealmaking is a key driver of innovation and growth for life sciences companies. Regulation, complexity, scientific discovery and uncertainty are hallmarks of the sector, but can lead to higher-than-average attrition rates for deals.

This report, based on interviews with life sciences dealmaking veterans, looks at key risk factors for buyers and sellers in life sciences deals - and how to avoid them to increase the probability of deal success.

Please complete the form to download the report.